Cannabinoid Medicines Are Generally Safe for Older Adults, With Dose-Dependent Side Effects
A meta-analysis of 58 RCTs found THC-containing cannabinoid medicines increase common side effects (dry mouth, dizziness, drowsiness) in a dose-dependent manner in adults 50+, but serious adverse events, withdrawals, and deaths were not significantly higher than controls.
Quick Facts
What This Study Found
THC alone and THC:CBD combinations significantly increased all-cause and treatment-related adverse events compared to controls. However, serious adverse events, study withdrawals, and deaths were not significantly increased. THC dose-dependently increased dry mouth, dizziness, balance problems, dissociative/thinking issues, and drowsiness. The interaction of THC:CBD doses influenced neurological, psychiatric, and cardiac side effects.
Key Numbers
58 RCTs, 6,611 participants, mean age 50-87. THC alone IRD for all AEs: 18.83 (CI: 1.47-55.79). THC:CBD IRD: 19.37 (CI: 4.24-45.47). No significant increase in serious AEs, withdrawals, or deaths. Dose-dependent: dry mouth, dizziness, balance, dissociative symptoms, drowsiness.
How They Did This
Systematic review and meta-analysis of 58 RCTs (37 moderate-high quality) with pooled n=6,611 participants (mean age 50-87 years, 50% male, 3,450 receiving CBMs). Searched 7 databases from 1990-2023. Estimated incidence rate differences under random-effects model.
Why This Research Matters
Older adults are the fastest-growing demographic of cannabinoid medicine users, yet most safety data comes from younger populations. This meta-analysis specifically addresses the 50+ age group, providing age-appropriate safety data for clinical decision-making.
The Bigger Picture
The finding that cannabinoid medicines are generally safe but have predictable, dose-dependent side effects in older adults provides the evidence base for careful dose titration rather than avoidance. This aligns with the geriatric medicine principle of "start low, go slow."
What This Study Doesn't Tell Us
RCT populations may be healthier than real-world older cannabis users. Most trials were relatively short-term. The wide confidence intervals for some outcomes reflect heterogeneity. CBD-only medicines were not separately analyzed in the abstract.
Questions This Raises
- ?What is the optimal starting dose for older adults?
- ?Do the balance and cognitive side effects translate to increased fall risk?
- ?How do cannabinoid side effects compare to those of medications they might replace (opioids, benzodiazepines)?
Trust & Context
- Key Stat:
- No significant increase in serious adverse events or deaths in 50+ adults
- Evidence Grade:
- Large meta-analysis of 58 RCTs specifically focused on older adults, providing strong evidence for the safety profile in this population.
- Study Age:
- 2024 meta-analysis
- Original Title:
- Adverse events caused by cannabinoids in middle aged and older adults for all indications: a meta-analysis of incidence rate difference.
- Published In:
- Age and ageing, 53(11) (2024)
- Authors:
- Velayudhan, Latha(3), Pisani, Sara(2), Dugonjic, Marta, McGoohan, Katie, Bhattacharyya, Sagnik
- Database ID:
- RTHC-05781
Evidence Hierarchy
Combines results from multiple studies to find an overall pattern.
What do these levels mean? →Frequently Asked Questions
Are cannabinoid medicines safe for older adults?
This meta-analysis of 58 trials found cannabinoid medicines are generally safe in adults 50+. Common side effects (dry mouth, dizziness, drowsiness) increase with dose, but serious adverse events and deaths were not significantly higher than placebo.
What side effects should older adults expect from cannabis medicines?
Dry mouth, dizziness/lightheadedness, balance problems, thinking difficulties, and drowsiness are the most common, all increasing with THC dose. These are important for fall prevention in older adults.
Read More on RethinkTHC
- cannabis-cardiovascular-heart-risk-stroke
- cannabis-heart-cardiovascular-risk
- coughing-up-stuff-after-quitting-weed
- lung-recovery-after-quitting-smoking-weed
- lung-recovery-quitting-weed
- quitting-weed-female-hormones
- quitting-weed-weight-gain-loss-diet-appetite
- sex-after-quitting-weed
- weed-DUI-driving-impaired-cannabis-laws
- weed-acne-skin
- weed-fertility-sperm
- weed-gut-digestion-problems
- weed-heart-health
- weed-testosterone-levels
Cite This Study
https://rethinkthc.com/research/RTHC-05781APA
Velayudhan, Latha; Pisani, Sara; Dugonjic, Marta; McGoohan, Katie; Bhattacharyya, Sagnik. (2024). Adverse events caused by cannabinoids in middle aged and older adults for all indications: a meta-analysis of incidence rate difference.. Age and ageing, 53(11). https://doi.org/10.1093/ageing/afae261
MLA
Velayudhan, Latha, et al. "Adverse events caused by cannabinoids in middle aged and older adults for all indications: a meta-analysis of incidence rate difference.." Age and ageing, 2024. https://doi.org/10.1093/ageing/afae261
RethinkTHC
RethinkTHC Research Database. "Adverse events caused by cannabinoids in middle aged and old..." RTHC-05781. Retrieved from https://rethinkthc.com/research/velayudhan-2024-adverse-events-caused-by
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.